Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $362.05, but opened at $392.03. Astera Labs shares last traded at $377.7940, with a volume of 538,476 shares trading hands.
Analyst Ratings Changes
Several brokerages have commented on ALAB. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Bank of America lifted their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Stifel Nicolaus boosted their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Morgan Stanley upped their price objective on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Roth Capital reiterated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $275.75.
Check Out Our Latest Analysis on Astera Labs
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the sale, the chief executive officer directly owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,037,724 shares of company stock worth $507,157,341. 10.40% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Astera Labs
A number of institutional investors have recently made changes to their positions in ALAB. Accel Wealth Management bought a new stake in shares of Astera Labs in the 2nd quarter valued at about $317,000. Handelsbanken Fonder AB lifted its stake in shares of Astera Labs by 11.3% in the second quarter. Handelsbanken Fonder AB now owns 44,500 shares of the company’s stock worth $21,494,000 after acquiring an additional 4,500 shares during the period. Redhawk Wealth Advisors Inc. bought a new stake in Astera Labs in the second quarter valued at approximately $331,000. Wealthcare Advisory Partners LLC increased its position in Astera Labs by 0.9% during the 2nd quarter. Wealthcare Advisory Partners LLC now owns 22,845 shares of the company’s stock valued at $11,035,000 after purchasing an additional 201 shares during the period. Finally, Focus Financial Network Inc. acquired a new stake in Astera Labs during the 2nd quarter valued at approximately $711,000. Institutional investors own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
